You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 15, 2025

Drug Price Trends for NDC 70095-0050


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 70095-0050

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for the Drug NDC: 70095-0050

Understanding the National Drug Code (NDC)

To delve into the market analysis and price projections for a specific drug identified by its NDC (National Drug Code), it is crucial to first understand what an NDC is and its significance in the healthcare industry.

The NDC is a unique 11-digit code assigned to each drug product by the FDA. It is composed of three segments: the labeler code, the product code, and the package code. This code is essential for tracking drugs from the manufacturer to the point of sale, ensuring accurate ordering, inventory management, and billing[1][4].

Identifying the Drug

The NDC 70095-0050 corresponds to a specific drug product. However, without specific details on the drug name, we need to consider general trends and factors influencing drug prices and market projections.

Market Trends in Pharmaceutical Pricing

Drug Price Inflation

The pharmaceutical market is experiencing significant price inflation, particularly driven by specialty pharmaceuticals. According to Vizient, Inc., drug price inflation is projected to grow at 3.8% in 2024, with specialty pharmaceuticals being a major contributor. This trend is influenced by the increasing utilization of high-cost drugs for complex and chronic conditions such as cancer, autoimmune diseases, and pulmonary conditions[2].

Impact of Specialty Pharmaceuticals

Specialty pharmaceuticals, which include drugs for conditions like non-small cell lung cancer (NSCLC), are expected to drive significant market growth. For instance, immunotherapies like Keytruda, Opdivo, and Tecentriq are projected to achieve blockbuster status, with sales reaching $17.5 billion by 2025. Targeted therapies, such as Tagrisso and Avastin, also contribute substantially to the market growth[3].

Price Projections

General Pricing Trends

For drugs like those identified by NDC 70095-0050, several factors influence price projections:

  • Inflation and Market Demand: As seen with specialty pharmaceuticals, high demand and limited supply can drive up prices.
  • Regulatory Changes: Initiatives like the Medicare Drug Price Negotiation Program aim to reduce drug prices. For example, negotiated prices for certain drugs under Medicare Part D are expected to result in discounts ranging from 38% to 79% compared to list prices[5].

Specific to NDC 70095-0050

Without specific details on the drug, we can infer the following:

  • If it is a specialty pharmaceutical, it is likely to follow the trend of increasing prices due to high demand and the complexity of the conditions it treats.
  • If it is a generic or biosimilar, prices might be more stable or even decrease due to competition. For instance, biosimilars are expected to increase in market share, which can lead to lower prices compared to their branded counterparts[2].

Market Analysis

Supply Chain and Distribution

The NDC plays a critical role in ensuring the accurate tracking and distribution of drugs. Any disruptions in the supply chain or changes in distribution strategies can impact the availability and pricing of the drug[1].

Regulatory Environment

Changes in FDA regulations, such as the proposed move to a 12-digit NDC format, can also influence how drugs are listed and tracked. This could have implications for inventory management and billing processes, potentially affecting prices[1].

Patient Compliance and Safety

Correct assignment of the NDC is crucial for patient safety and compliance. Incorrect assignments can lead to safety concerns and billing issues, which can indirectly affect market dynamics and pricing[1].

Key Takeaways

  • NDC Significance: The NDC is a critical identifier for drugs in the U.S., ensuring accurate tracking and distribution.
  • Market Trends: Specialty pharmaceuticals are driving significant price inflation, while regulatory changes and biosimilar competition can stabilize or reduce prices.
  • Price Projections: Without specific details, it is challenging to predict exact price changes, but general trends suggest that specialty drugs will continue to see price increases, while generics and biosimilars may see more stable or decreasing prices.
  • Regulatory Impact: Changes in FDA regulations and supply chain dynamics can influence drug pricing and market projections.

FAQs

What is the National Drug Code (NDC)?

The NDC is a unique 11-digit code assigned to each drug product by the FDA, used for tracking, ordering, and billing.

How does the NDC affect drug pricing?

The NDC ensures accurate tracking and billing, which can indirectly affect pricing by preventing errors and ensuring compliance.

What are the key drivers of drug price inflation?

Specialty pharmaceuticals, particularly those treating complex and chronic conditions, are major drivers of drug price inflation.

How do regulatory changes impact drug prices?

Regulatory changes, such as the Medicare Drug Price Negotiation Program, can significantly reduce drug prices through negotiated discounts.

What role do biosimilars play in drug pricing?

Biosimilars can reduce prices by increasing competition with branded drugs, leading to lower costs for patients and healthcare providers.

Sources

  1. FDA Drug Topics Webinar: National Drug Code (NDC) for Healthcare Providers.
  2. Vizient, Inc.: Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals.
  3. GlobalData: NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025.
  4. FDA: National Drug Code Directory.
  5. ASPE - HHS.gov: Medicare Drug Price Negotiation Program.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.